| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |